We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil

Written answer

Medicinal Products

849. Deputy Conor Sheehan asked the Minister for Health the timeline that has been established by her Department and the HSE to ensure that eligible adults living with Spinal Muscular Atrophy (SMA) can access clinical assessments and subsequent Risdiplam treatment without delay. [78943/26]

Comment on this

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comment on this